Contact
CREATIO provides support in the development process of healthcare products (basic, preclinical research and clinical production) with the aim of increasing the efficiency of the healthcare system and quality of life.
Universitat de Barcelona (UB)
ATMP; cell therapy; gene therapy; tissue engineering; 3D bioprinting; quality system; clean rooms; preclinical studies; regulatory preclinical; drug screening; clinical production; consulting; GMP; ISO9001; GLP
Want more information about TECNIO Technology Developers?
Technological capabilities
Production of advanced therapy medicines for clinical use following GMP and ISO 9001 regulations: protocolization and documentation, production of the medicine, development of quality controls and validations, staff training and support in communication with the medicine agencies.
Preclinical studies of products and technologies in development to ISO9001, and GLP, if applicable: study route, review of documentation and studies carried out, protocolization, experimental phases, issuance of reports and support in communication with drug agencies.
Basic and translational research by contract or project, to ISO9001: in vitro, in vivo, in silico, or combined projects, for relocation and upscaling production of advanced therapy medicines according to GMP.
Scientific-technical consultancy and advice in the development of new activities and processes in advanced therapies, preclinical and clinical trials, GMP, GLP and ISO9001, and implementation and monitoring.
TOPTechnological fields
Biotechnology, Personalized medicine, Omics, Design new drugs / vaccines
Big Data + IA
Relevant equipment
Creatio has a total of 500 m2, including the preclinical research department and the clinical production department where the only 3D bioprinter under NCF in Spain is located.
CREATIO location
